PPT-Randomisation 2 : 1 Open-label
18 years HCV genotype 3 Treatmentnaïve HCV RNA gt 1 000 IUmL No cirrhosis No HBV coinfection No HIV coinfection ENDURANCE3 Study glecaprevir pibrentasvir vs SOF
Download Presentation
"Randomisation 2 : 1 Open-label" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.